当前位置: X-MOL 学术Annu. Rev. Pharmacol. Toxicol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Strategies to Develop Inhibitors of Motif-Mediated Protein-Protein Interactions as Drug Leads
Annual Review of Pharmacology and Toxicology ( IF 12.5 ) Pub Date : 2017-01-06 00:00:00 , DOI: 10.1146/annurev-pharmtox-010716-104805
Carles Corbi-Verge 1 , Michael Garton 1 , Satra Nim 1 , Philip M. Kim 1, 2, 3
Affiliation  

Protein-protein interactions are fundamental for virtually all functions of the cell. A large fraction of these interactions involve short peptide motifs, and there has been increased interest in targeting them using peptide-based therapeutics. Peptides benefit from being specific, relatively safe, and easy to produce. They are also easy to modify using chemical synthesis and molecular biology techniques. However, significant challenges remain regarding the use of peptides as therapeutic agents. Identification of peptide motifs is difficult, and peptides typically display low cell permeability and sensitivity to enzymatic degradation. In this review, we outline the principal high-throughput methodologies for motif discovery and describe current methods for overcoming pharmacokinetic and bioavailability limitations.

中文翻译:


发展作为药物线索的母体介导的蛋白质-蛋白质相互作用抑制剂的策略

蛋白质-蛋白质相互作用实际上是细胞所有功能的基础。这些相互作用的很大一部分涉及短肽基序,并且使用基于肽的治疗剂靶向它们的兴趣已经增加。肽得益于特异性,相对安全和易于生产。使用化学合成和分子生物学技术也很容易对其进行修饰。然而,关于使用肽作为治疗剂仍然存在重大挑战。肽基序的鉴定是困难的,并且肽通常显示出低的细胞渗透性和对酶促降解的敏感性。在这篇综述中,我们概述了用于基序发现的主要高通量方法,并描述了克服药代动力学和生物利用度限制的当前方法。

更新日期:2017-01-06
down
wechat
bug